Nicolas Gilles Selected Research

mambaquaretin-1

1/2017

Green mamba peptide targets type-2 vasopressin receptor against polycystic kidney disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicolas Gilles Research Topics

Disease

2	Disease Progression 01/2017 - 03/2011
1	Alzheimer Disease (Alzheimer's Disease) 11/2022
1	Obesity 01/2022
1	Hyponatremia 01/2020
1	Neoplasms (Cancer) 01/2020
1	Pain (Aches) 01/2019
1	Polycystic Kidney Diseases (Polycystic Kidney Disease) 01/2017
1	Cysts 01/2017

Drug/Important Bio-Agent (IBA)

2	LigandsIBA 01/2022 - 01/2020
2	Peptides (Polypeptides)IBA 01/2019 - 01/2017
1	CholesterolIBA 11/2022
1	setmelanotideIBA 01/2022
1	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 01/2020
1	Opioid Analgesics (Opioids)IBA 01/2019
1	Analgesics (Analgesic Drugs)IBA 01/2019
1	VenomsIBA 01/2019
1	mambaquaretin-1IBA 01/2017
1	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 01/2017
1	CopperIBA 03/2011
1	ZincIBA 03/2011